Skip to main content
Clinical Trials/IRCT20160307026950N12
IRCT20160307026950N12
Completed
Phase 3

Comparison of the effects of midazolam and dexmedetomidine on sedation levels, hemodynamics and complications in patients under brain stereotaxic surgery

Esfahan University of Medical Sciences0 sites64 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Condition 1: respiratory apnea. Condition 2: systolic and diastolic blood pressure. Condition 3: heart rate. Condition 4: drug sedation level. Condition 5: bleeding. Condition 6: oxygen saturation level.
Sponsor
Esfahan University of Medical Sciences
Enrollment
64
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • patients candidates brain stereotaxic surgery
  • age between 18 and 60
  • No history of allergic reaction to both midazolam and dexmedetomidin

Exclusion Criteria

  • any change in anesthesia or surgery plan due to any complication
  • patient expiration during surgery

Outcomes

Primary Outcomes

Not specified

Similar Trials